Control group:Conventional standardized treatment

3 trials

Sponsors

Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Affiliated hangzhou first people's hospital, zhejiang university school of medicine

Conditions

Lumbar intervertebral disc herniation with radiculopathyNovel Coronavirus Pneumonia (COVID-19)novel coronavirus pneumonia (COVID-19)

Early Phase 1

A randomized, open-label study to evaluate the efficacy and safety of Lopinavir-Ritonavir in patients with mild novel coronavirus pneumonia (COVID-19)

RecruitingChiCTR2000029539

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technologynovel coronavirus pneumonia (COVID-19)

Start: 2020-02-04Updated: 2020-02-17

Unknown Phase

A randomized, controlled open-label trial to evaluate the efficacy and safety of lopinavir-ritonavir in hospitalized patients with novel coronavirus pneumonia (COVID-19)

RecruitingChiCTR2000029308

Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital)Novel Coronavirus Pneumonia (COVID-19)

Start: 2020-01-10Updated: 2020-03-09

Study on the clinical efficacy and mechanism of tetrandrine in the treatment of patients with lumbar disc herniation

Active, not recruitingChiCTR2500108829

Affiliated hangzhou first people's hospital, zhejiang university school of medicineLumbar intervertebral disc herniation with radiculopathy

Start: 2025-09-09Updated: 2025-09-15

Related Papers

Impact of corticosteroids on initiation and half-year durability of humoral response in COVID-19 survivors.

2024-03-154 citations

Characterization of two SARS-CoV-2 subgenomic RNA dynamics in severe COVID-19 patients.

2022-01-173 citations

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

New England Journal of Medicine2020-03-185460 citations

Who Needs a Corona?

Arthritis & Rheumatology2020-03-176 citations